# A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

> **NCT04147325** · — · COMPLETED · sponsor: **Janssen-Cilag Farmaceutica Ltda.** · enrollment: 105 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Antiretroviral Therapy

## Key facts

- **NCT ID:** NCT04147325
- **Lead sponsor:** Janssen-Cilag Farmaceutica Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-17
- **Primary completion:** 2022-12-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147325, "A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04147325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*